Russia Quietly Changed Its Space Station Plans. Here's What That Means The proposed Russian Orbital Station will stick to a ...
As the war grinds on, sophisticated Russian defenses have pushed Ukraine to develop a frightening new weapon: semiautonomous ...
The F-35 program closes 2025 under the shadow of a new report from the Pentagon‘s Inspector General: millions in payments ...
Ultragenyx jumps after completing rolling BLA submission to the FDA for DTX401, an AAV gene therapy that could become the first approved treatment for GSDIa.
Black Book Survey of 417 European health IT leaders across nine countries finds "interoperability-first" is now a procurement gate; multilingual localization is driving adoption; and modular ...
NASA astronaut Zena Cardman processes bone cell samples inside the Kibo laboratory module's Life Science Glovebox. NASA 2025 ...
TipRanks on MSN
Ultragenyx completes BLA filing for GSDIa gene therapy
Ultragenyx Pharmaceutical ( ($RARE) ) just unveiled an update. On December 30, 2025, Ultragenyx Pharmaceutical announced it had completed the ...
A look at NASA’s Apollo 8 mission, its impact in 1968, and how Artemis 2 could shape the future of human spaceflight in 2026 ...
I always get nostalgic when I come to Houston, the “Space City,” as I did for Saturday’s Texas Bowl between LSU and the ...
If approved, DTX401 will be the first therapy approved to treat the underlying cause of GSDIaNOVATO, Calif., Dec. 30, 2025 ...
In commission-driven environments, anti-bribery and corruption (ABAC) violations don’t begin with overt misconduct. They ...
Amentum (NYSE: AMTM) delivered advanced end-to-end ground systems engineering for a key Artemis II launch rehearsal at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback